Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 27;16(1):20.
doi: 10.1186/s13011-021-00354-1.

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway

Collaborators, Affiliations

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway

Christer Frode Aas et al. Subst Abuse Treat Prev Policy. .

Abstract

Background: There is high co-occurrence of substance use disorders (SUD) and mental health disorders. We aimed to assess impact of substance use patterns and sociodemographic factors on mental health distress using the ten-item Hopkins Symptom Checklist (SCL-10) over time.

Methods: Nested prospective cohort study of 707 participants with severe SUD across nine opioid-agonist-therapy outpatient clinics and low-threshold municipality clinics in Norway, during 2017-2020. Descriptive statistics were derived at baseline and reported by means and standard deviation (SD). A linear mixed model analysis was used to assess the impact of substance use patterns and sociodemographic factors on SCL-10 sum score with beta coefficients with 95% confidence intervals (CI).

Results: Mean (SD) SCL-10 score was 2.2 (0.8) at baseline with large variations across patients. We observed more symptoms of mental health disorders among people with frequent use of benzodiazepines (beta 3.6, CI:2.4;4.8), cannabis (1.3, CI:0.2;2.5), opioids (2.7, CI:1.1;4.2), and less symptoms among people using frequent stimulant use (- 2.7, CI:-4.1;-1.4) compared to no or less frequent use. Females (1.8, CI:0.7;3.0) and participants with debt worries (2.2, CI:1.1;3.3) and unstable living conditions (1.7, CI:0.0;3.3) had also higher burden of mental health symptoms. There were large individual variations in SCL-10 score from baseline to follow-up, but no consistent time trends indicating change over time for the whole group. 65% of the cohort had a mean score > 1.85, the standard reference score.

Conclusions: People with SUD have a considerable burden of mental health symptoms. We found no association between substance use patterns and change in mental health symptoms over time. This could suggest that the differences observed were indicating flattening of effects or self-medication to a larger degree than medication-related decline in mental health. This call for better individualized mental health assessment and patient care.

Keywords: Mental disorder; Mental health problems; Opioid dependence; Opioid substitution treatment; Psychological distress; Substance abuse; Substance use disorder.

PubMed Disclaimer

Conflict of interest statement

None of the authors have competing interests.

Figures

Fig. 1
Fig. 1
Proportion of SCL-10 item scores at baseline. SCL-10 = Symptoms checklist 10; ten items scale for measuring mental health status/psychological distress. The figure displays the proportion of patients responses on the ten item scale, from not bothered at all (item score= 1) to extremely bothered (item score = 4)
Fig. 2
Fig. 2
Pen’s Parade: Distribution of mean SCL-10 item scores at baseline and follow-up. Pen’s Parade: SCL-10 = Symptoms checklist 10; ten items scale for measuring mental health status/psychological distress. The figure displays distribution in SCL-10 mean values at baseline (n=707) and follow up (n=268), represented by fixed black line and vertical grey lines. The dotted lines represent the mean reported SCL-10 score of the Norwegian reference population (1.36) and standard reference of 1.85 indicating one or more mental disorders above this cut-off, respectively. Source: Strand BH, Dalgard OS, Tambs K, Rognerud M: Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nordic journal of psychiatry 2003 [31]

References

    1. Global Burden of Disease Collaborative Network The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the global burden of disease study 2016. The lancet Psychiatry. 2018;5(12):987–1012. doi: 10.1016/S2215-0366(18)30337-7. - DOI - PMC - PubMed
    1. Santucci K. Psychiatric disease and drug abuse. Curr Opin Pediatr. 2012;24(2):233–237. doi: 10.1097/MOP.0b013e3283504fbf. - DOI - PubMed
    1. Burdzovic Andreas J, Lauritzen G, Nordfjaern T. Co-occurrence between mental distress and poly-drug use: a ten year prospective study of patients from substance abuse treatment. Addict Behav. 2015;48:71–78. doi: 10.1016/j.addbeh.2015.05.001. - DOI - PubMed
    1. Chassin L, Sher KJ, Hussong A, Curran P. The developmental psychopathology of alcohol use and alcohol disorders: research achievements and future directions. Dev Psychopathol. 2013;25(4 Pt 2):1567–1584. doi: 10.1017/S0954579413000771. - DOI - PMC - PubMed
    1. Bramness JG, Gundersen OH, Guterstam J, Rognli EB, Konstenius M, Løberg EM, Medhus S, Tanum L, Franck J. Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry. 2012;12:221. doi: 10.1186/1471-244X-12-221. - DOI - PMC - PubMed

Publication types

Substances